Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
Glipizide 10 mg po daily
HCTZ 25 mg daily
Atenolol 25 mg po daily
Hydralazine 25 mg qid
Simvastatin 80 mg daily
Verapamil 180 mg CD daily
Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
PLEASE ANSWER THIS FULLY I HAVE BEEN GETTING 2 SENTENCE ANSWERS AND THAT DOESN'T HELP ANSWER THE QUESTION.
ANS:- The combination of ATENOLOL, HCTZ AND VERAPAMIL can affect the patient hemodynamic respond, which can lead to hypotension, angina, congestive heart faliure, arrythmia which can show symptoms like chest pain, irregular heartbeat.
The patient taking GLIPIZIDE AND ATENOLOL. Beta blocker such as ATENOLOL can increase the risk and duration of hypoglycemic symptoms while on the other hand beta blocker(ATENOLOL) also mask the symptoms of hypoglycemia.
Therefore condition such as hypotension, diabetes and hyperlipidemia can cause a huge impact on patients recommend drug therapy.
Get Answers For Free
Most questions answered within 1 hours.